Yeji Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yeji Kim has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Abraham Chachoua
NYU Langone Health 4 Department of Medicine, New York University Grossman School of Medicine New York, New York
1 shared publication - Alexander Bain
NYU Langone Health 1 Division of Pulmonary and Critical Care Medicine, New York UniversityGrossman School of Medicine New York, New York
1 shared publication - Andrew DeMaio
NYU Langone Health 1 Division of Pulmonary and Critical Care Medicine, New York UniversityGrossman School of Medicine New York, New York
1 shared publication - Anton Sebastian Becker
NYU Langone Health 9 Department of Radiology, New York University Grossman School of Medicine New York, New York
1 shared publication - Aristotelis Tsirigos
Department of Pathology, New York University Grossman School of Medicine, New York, USA
1 shared publication - Benjamin G. Wu
NYU Langone Health 1 Division of Pulmonary and Critical Care Medicine, New York UniversityGrossman School of Medicine New York, New York
1 shared publication
Latest Publications
- 12 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- p. OF1-OF20
Lower Airway Microbiome Transcriptional and Metabolic Activities Influence Responsiveness to Immunotherapy in NSCLC
Immune checkpoint inhibitors (ICI) have transformed the treatment of advanced non–small cell lung cancer (NSCLC), yet a large proportion of patients do not respond. The lung microbiome is a key modulator of antitumor immunity; however, the functional contribution of active microbial communities and their interaction with host transcriptional programs in shaping ICI outcomes remain poorly defined. In this study, we prospectively analyzed bronchoalveolar lavage (BAL) samples from 71 patients with NSCLC prior to ICI initiation. We profiled the microbiome and host transcriptome in the BAL to look for microbial and host signatures in the lower airways associated with treatment response. We found that enrichment of the lower airway microbiome with oral commensals was associated with disease progression and worse prognosis of patients treated with ICIs. Metatranscriptomics-derived microbial clustering revealed distinct functional profiles. The microbial cluster enriched with oral commensals, which was only present among patients with poor response to ICIs, had differential regulation of pathways involved in the metabolism of short-chain fatty acids, methane, and pyruvate. This cluster also correlated with host immune pathways including upregulation of interferon signaling, neutrophil degranulation, and mitophagy, all of which could contribute to the poor response to immunotherapy. In a preclinical murine model of lung cancer with dysbiosis, inoculating lung tumor–bearing mice with oral commensals increased intratumoral neutrophils and Th17 responses and impaired ICI efficacy. Our findings support the concept that microbial communities in the lower airways influence tumor–immune interactions via defined metabolic–immune axes. Significance: Transcriptionally active lower airway microbial communities are linked clinically and preclinically to immunotherapy response in NSCLC, identifying microbial activity as a functional interface with the tumor microenvironment and a potential therapeutic target.
- 12 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- p. OF1-OF20
Lower Airway Microbiome Transcriptional and Metabolic Activities Influence Responsiveness to Immunotherapy in NSCLC
Immune checkpoint inhibitors (ICI) have transformed the treatment of advanced non–small cell lung cancer (NSCLC), yet a large proportion of patients do not respond. The lung microbiome is a key modulator of antitumor immunity; however, the functional contribution of active microbial communities and their interaction with host transcriptional programs in shaping ICI outcomes remain poorly defined. In this study, we prospectively analyzed bronchoalveolar lavage (BAL) samples from 71 patients with NSCLC prior to ICI initiation. We profiled the microbiome and host transcriptome in the BAL to look for microbial and host signatures in the lower airways associated with treatment response. We found that enrichment of the lower airway microbiome with oral commensals was associated with disease progression and worse prognosis of patients treated with ICIs. Metatranscriptomics-derived microbial clustering revealed distinct functional profiles. The microbial cluster enriched with oral commensals, which was only present among patients with poor response to ICIs, had differential regulation of pathways involved in the metabolism of short-chain fatty acids, methane, and pyruvate. This cluster also correlated with host immune pathways including upregulation of interferon signaling, neutrophil degranulation, and mitophagy, all of which could contribute to the poor response to immunotherapy. In a preclinical murine model of lung cancer with dysbiosis, inoculating lung tumor–bearing mice with oral commensals increased intratumoral neutrophils and Th17 responses and impaired ICI efficacy. Our findings support the concept that microbial communities in the lower airways influence tumor–immune interactions via defined metabolic–immune axes. Significance: Transcriptionally active lower airway microbial communities are linked clinically and preclinically to immunotherapy response in NSCLC, identifying microbial activity as a functional interface with the tumor microenvironment and a potential therapeutic target.
- Open Access
- 14 November 2024
- Published by Wiley in Biometrical Journal
- Vol. 66 (8) , e70001
Inverse‐Weighted Quantile Regression With Partially Interval‐Censored Data
This paper introduces a novel approach to estimating censored quantile regression using inverse probability of censoring weighted (IPCW) methodology, specifically tailored for data sets featuring partially interval‐censored data. Such data sets, often encountered in HIV/AIDS and cancer biomedical research, may include doubly censored (DC) and partly interval‐censored (PIC) endpoints. DC responses involve either left‐censoring or right‐censoring alongside some exact failure time observations, while PIC responses are subject to interval‐censoring. Despite the existence of complex estimating techniques for interval‐censored quantile regression, we propose a simple and intuitive IPCW‐based method, easily implementable by assigning suitable inverse‐probability weights to subjects with exact failure time observations. The resulting estimator exhibits asymptotic properties, such as uniform consistency and weak convergence, and we explore an augmented‐IPCW (AIPCW) approach to enhance efficiency. In addition, our method can be adapted for multivariate partially interval‐censored data. Simulation studies demonstrate the new procedure's strong finite‐sample performance. We illustrate the practical application of our approach through an analysis of progression‐free survival endpoints in a phase III clinical trial focusing on metastatic colorectal cancer.
- 14 November 2024
- Published by Wiley in Biometrical Journal
- Vol. 66 (8) , e70001
Open AccessInverse‐Weighted Quantile Regression With Partially Interval‐Censored Data
This paper introduces a novel approach to estimating censored quantile regression using inverse probability of censoring weighted (IPCW) methodology, specifically tailored for data sets featuring partially interval‐censored data. Such data sets, often encountered in HIV/AIDS and cancer biomedical research, may include doubly censored (DC) and partly interval‐censored (PIC) endpoints. DC responses involve either left‐censoring or right‐censoring alongside some exact failure time observations, while PIC responses are subject to interval‐censoring. Despite the existence of complex estimating techniques for interval‐censored quantile regression, we propose a simple and intuitive IPCW‐based method, easily implementable by assigning suitable inverse‐probability weights to subjects with exact failure time observations. The resulting estimator exhibits asymptotic properties, such as uniform consistency and weak convergence, and we explore an augmented‐IPCW (AIPCW) approach to enhance efficiency. In addition, our method can be adapted for multivariate partially interval‐censored data. Simulation studies demonstrate the new procedure's strong finite‐sample performance. We illustrate the practical application of our approach through an analysis of progression‐free survival endpoints in a phase III clinical trial focusing on metastatic colorectal cancer.
- Open Access
- 1 January 2019
- Published by Korean Ophthalmological Society in Journal of the Korean Ophthalmological Society
- Vol. 60 (9) , 874-880
Retinal Nerve Fiber Layer and Macular Retinal Ganglion Cell Layer Thicknesses in Healthy Korean Children
Kim Y, et al. J Korean Ophthalmol Soc. 2019 Sep;60(9):874-880. https://doi.org/10.3341/jkos.2019.60.9.874
- 1 January 2019
- Published by Korean Ophthalmological Society in Journal of the Korean Ophthalmological Society
- Vol. 60 (9) , 874-880
Open AccessRetinal Nerve Fiber Layer and Macular Retinal Ganglion Cell Layer Thicknesses in Healthy Korean Children
Kim Y, et al. J Korean Ophthalmol Soc. 2019 Sep;60(9):874-880. https://doi.org/10.3341/jkos.2019.60.9.874